Mild Cognitive Impairment

Mild behavioral impairment associated with raised p-tau181 and increased risk of dementia

EXERT results: exercise shown to stall cognitive decline in patients with mild cognitive impairment

Prognostic value of blood-based biomarkers in predicting progression to dementia from SCD/MCI

Investigating aerobic exercise and cognition in older adults

Design of the Phase III EXERT trial of aerobic exercise in mild cognitive impairment

Subjective cognitive decline as a preclinical phase of Alzheimer’s disease

Diagnosing mild cognitive impairment

Predictive factors of progression from mild cognitive impairment to dementia

Possible causes of empathy deficits in patients with MCI or Alzheimer’s disease

Potential of anti-amyloid drugs for treating Alzheimer’s disease

Plasma NfL levels as a potential biomarker in MCI and Alzheimer’s disease

Predicting conversion to Alzheimer’s disease with plasma NfL

Ethical considerations when investigating the causes of mild cognitive impairment

Non-pharmacological interventions to prevent dementia progression

Financial capacity assessment in dementia patients: a new prediction tool for disease progression?

The promise of data science for the study of dementia